AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

863.185

-8.198-0.94%

Number of Gainers:12

Number of Losers:18

Number of Flat:16

PE:- -

High:871.441

Open:871.383

Low:858.404

Close:871.383

Loading ...

Respiri Ltd - Enters Partnership With Evolent Care Partners' to Deliver Care Management Services in Hawaii

THOMSON REUTERS

Arcadium Lithium to be Delisted From ASX 200 Index

MT Newswires Live

5 high-quality ASX ETFs to buy in March

Monash IVF Group (ASX:MVF) Is Increasing Its Dividend To A$0.026

Simply Wall St.

When Will Imricor Medical Systems, Inc. (ASX:IMR) Breakeven?

Simply Wall St.

Press Release: Opthea Reports Half Year Results and Business Updates

BRIEF-Genetic Technologies's Creditors Resolve To Execute Benelong DOCA

BRIEF-Cann Group Posts HY Loss From Ordinary Activities After Tax A$10.7 Million

Cann Group Agrees to Drawdown on Convertible Loan Facility

MT Newswires Live

Genetic Technologies - Creditors Resolve to Execute Benelong Doca

THOMSON REUTERS

Small companies, big swings and four future leaders that stand out

Cann Group Ltd - Hy Loss From Ordinary Activities After Tax a$10.7 Mln

THOMSON REUTERS

Proteomics Opens Certified Clinical Laboratory in California; Shares Fall 8%

MT Newswires Live

Why did the ASX 200 go backwards in February?

Neuren Pharmaceuticals Receives First Milestone Payment for Rett Syndrome Drug; Shares Down 6%

MT Newswires Live

BRIEF-Biotron Says Renounceable Rights Issue To Raise Up To A$2.7 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":863.1849,"timestamp":1741237199889,"preClose":871.38275,"halted":0,"volume":66121544,"delay":0,"changeRate":-0.009408,"change":-8.197876,"amount":173611356,"amplitude":0.014961,"prevYearClose":936.801,"fiveDayClose":865.483,"twentyDayClose":911.777,"turnoverRate":0.001788,"marketCap":138819092578.25,"floatMarketCap":135471653394.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":871.4405,"amplitude":0.014961,"preClose":871.38275,"low":858.4041,"latestPrice":863.1849,"volume":66121544,"delay":0,"open":871.3828,"prevYearClose":936.801,"prevWeekClose":863.841,"prevMonthClose":863.841,"prevQuarterClose":936.801,"fiveDayClose":865.483,"twentyDayClose":911.777,"sixtyDayClose":930.491,"secType":"PLATE","market":"AU","turnoverRate":0.001788,"marketCap":138819092578.25,"floatMarketCap":135471653394.25,"timestamp":1741237199889,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":12,"down":18,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:16,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516540553","title":"Respiri Ltd -  Enters Partnership With Evolent Care Partners' to Deliver Care Management Services in Hawaii","url":"https://stock-news.laohu8.com/highlight/detail?id=2516540553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516540553?lang=en_us&edition=fundamental","pubTime":"2025-03-03 06:27","pubTimestamp":1740954422,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250302:nFWN3PL008:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7508","RSH.AU","BK7503"],"gpt_icon":0},{"id":"2516846547","title":"Arcadium Lithium to be Delisted From ASX 200 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2516846547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516846547?lang=en_us&edition=fundamental","pubTime":"2025-03-03 05:31","pubTimestamp":1740951065,"startTime":"0","endTime":"0","summary":"Arcadium Lithium  will be removed from the S&P/ASX 200 index as the company will be acquired by Rio Tinto , according to a Friday Australian bourse filing.S&P Dow Jones Indices will remove Arcadium Lithium from the S&P/ASX 200 before the opening of trading on March 6 and replace it with Mesoblast , the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PLS.AU","BK7508","RIO.AU","BK7067","BK7511","ALTM","BK4144","BK7507","LTM.AU","BK7095","BK7501","MSB.AU","BK7036","BK4109"],"gpt_icon":0},{"id":"2516154781","title":"5 high-quality ASX ETFs to buy in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2516154781","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516154781?lang=en_us&edition=fundamental","pubTime":"2025-03-03 04:24","pubTimestamp":1740947084,"startTime":"0","endTime":"0","summary":"For investors looking to diversify their portfolios and gain exposure to strong-performing sectors or indices, exchange-traded funds (ETFs) can be a great way to do it. That's because ASX ETFs offer a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/03/5-high-quality-asx-etfs-to-buy-in-march/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4581","IVV","BK7508","ATEC.AU","BK4559","CBA.AU","SSO","BK4585",".SPX","BK4550","OEF","SH","XJO.AU","XAO.AU","FDN","BK7507","ASIA.AU","BK7511","SDS","CSL.AU","BK4534","OEX","UPRO","SPXU","BHP.AU","VOO","WTC.AU","BK7067","BK4588","VAS.AU","BK4504","BK7135","BK7503","MOAT.AU","BK7095","XKO.AU","XRO.AU","ESmain","BK7016","SPY","IVV.AU","BK7501"],"gpt_icon":0},{"id":"2516620225","title":"Monash IVF Group (ASX:MVF) Is Increasing Its Dividend To A$0.026","url":"https://stock-news.laohu8.com/highlight/detail?id=2516620225","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516620225?lang=en_us&edition=fundamental","pubTime":"2025-03-02 07:17","pubTimestamp":1740871079,"startTime":"0","endTime":"0","summary":"Monash IVF Group Limited  will increase its dividend on the 11th of April to A$0.026, which is 4.0% higher than last year's payment from the same period of A$0.025. This will take the annual payment to 4.1% of the stock price, which is above what most companies in the industry pay.Check out our latest analysis for Monash IVF Group. Monash IVF Group Might Find It Hard To Continue The Dividend. Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. While Monash IVF Group is not profitable, it is paying out less than 75% of its free cash flow, which means that there is plenty left over for reinvestment into the business. In general, cash flows are more important than the more traditional measures of profit so we feel pretty comfortable with the dividend at this level.Over the next year, EPS is forecast to rise by 15.7%. While it is good to see income moving in the right direction, it still looks like the company won't achieve profitability. H","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/monash-ivf-group-asx-mvf-231759766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU1670710661.SGD","LU1670711040.USD","BK4585","LU1670711123.USD","VFC","BK7113","BK4504","BK7508","BK4588","MVF.AU","LU1670710588.SGD","BK4202","MVF"],"gpt_icon":0},{"id":"2516344307","title":"When Will Imricor Medical Systems, Inc. (ASX:IMR) Breakeven?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344307","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516344307?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:44","pubTimestamp":1740779079,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Imricor Medical Systems, Inc.'s  business as it appears the company may be on the cusp of a considerable accomplishment. Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging  compatible products for cardiac catheter ablation procedures in the United States. The AU$427m market-cap company posted a loss in its most recent financial year of US$23m and a latest trailing-twelve-month loss of US$20m shrinking the gap between loss and breakeven. The most pressing concern for investors is Imricor Medical Systems' path to profitability – when will it breakeven?Below we will provide a high-level summary of the industry analysts’ expectations for the company.View our latest analysis for Imricor Medical Systems. According to some industry analysts covering Imricor Medical Systems, breakeven is near. They anticipate the company to incur a final loss in 2026, before generating po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-medical-systems-inc-asx-214439083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MRI.AU","BK7503","BK7057","BK7508","BK7007","IMR.AU"],"gpt_icon":0},{"id":"2514585323","title":"Press Release: Opthea Reports Half Year Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514585323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514585323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744000,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents of $131.9M as of December 31, 2024. Cash runway extends through anticipated topline data readouts of COAST  and ShORe . \"Opthea is making significant progress on its mission to deliver superior vision to patients with wet AMD enabling them to live fuller and healthier lives,\" said Frederic Guerard, PharmD, Chief Executive Officer of Opthea. \"Sozinibercept has the potential to be the first product in nearly 20 years to demonstrate superior visual outcomes in combination with standard of care therapy, and we look forward to the anticipated topline data readouts of our two Phase 3 clinical trials in early Q2 and mid-calendar year 2025.\". Tom Reilly, Chief Financial Officer of Opthea, added: \"Looking ahead, we expect our cash and cash equivalents to fund the Company through the anticipated topline data readouts of the Phase 3 COAST and ShORe trials. In addition, we continue to progress our manufacturing  activities as we prepare our Biologics License Application  ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880398471.USD","LU0170899867.USD","BK4529","GFS","LU1316542783.SGD","LU1951198990.SGD","IE00BMPRXN33.USD","LU0823434583.USD","OPT.AU","LU1852331112.SGD","BK4585","LU2458330169.SGD","LU0979878070.USD","CMC","LU0149725797.USD","BK4566","LU0127658192.USD","LU1951200564.SGD","BK7508","IE00B5949003.HKD","BK4573","LU2250418816.HKD","BK4575","LU0642271901.SGD","BK7067","LU0971096721.USD","LU1303367103.USD","IE00BHPRN162.USD","LU0390134368.USD","IE00BMPRXR70.SGD","IE0009356076.USD","BK4141","LU0719512351.SGD","LU2360106780.USD","LU2098885051.SGD","BK4543","LU0823421416.USD","BK4006","OPT","LU0823421333.USD","BK4532","LU1803068979.SGD","LU1923623000.USD","IE00BKVL7J92.USD","LU0889565833.HKD","BK4139","LU1989764664.SGD","LU2458330243.SGD","LU0056508442.USD"],"gpt_icon":1},{"id":"2514314534","title":"BRIEF-Genetic Technologies's Creditors Resolve To Execute Benelong DOCA","url":"https://stock-news.laohu8.com/highlight/detail?id=2514314534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514314534?lang=en_us&edition=fundamental","pubTime":"2025-02-28 16:15","pubTimestamp":1740730533,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Technologies's Creditors Resolve To Execute Benelong DOCAFeb 28 (Reuters) - Genetic Technologies Ltd GTG.AX:CREDITORS RESOLVE TO EXECUTE BENELONG DOCAFurther company coverage: GTG.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2AE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","GTG.AU","BK7508"],"gpt_icon":0},{"id":"2514313487","title":"BRIEF-Cann Group Posts HY Loss From Ordinary Activities After Tax A$10.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514313487","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514313487?lang=en_us&edition=fundamental","pubTime":"2025-02-28 15:25","pubTimestamp":1740727549,"startTime":"0","endTime":"0","summary":"BRIEF-Cann Group Posts HY Loss From Ordinary Activities After Tax A$10.7 MillionFeb 28 (Reuters) - Cann Group Ltd CAN.AX:HY LOSS FROM ORDINARY ACTIVITIES AFTER TAX A$10.7 MILLIONHY REVENUES FROM ORDINARY ACTIVITIES A$6.5 MILLIONFurther company coverage: CAN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAN.AU","BK7502","BK7508","BK7096"],"gpt_icon":0},{"id":"2514213392","title":"Cann Group Agrees to Drawdown on Convertible Loan Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2514213392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514213392?lang=en_us&edition=fundamental","pubTime":"2025-02-28 14:20","pubTimestamp":1740723617,"startTime":"0","endTime":"0","summary":"Cann Group  said it agreed to a AU$750,000 drawdown on its convertible note facility with Obsidian Global on Thursday, according to a Friday Australian bourse filing.The facility agreement was amended to enable the drawdown to occur in two stages.In the first stage, AU$150,000 will be drawn down, while AU$600,000 for the second stage will be received following the filing of an applicable prospectus.The firm's shares fell over 1% on market close on Friday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","CAN.AU","BK7502"],"gpt_icon":0},{"id":"2514739123","title":"Genetic Technologies - Creditors Resolve to Execute Benelong Doca","url":"https://stock-news.laohu8.com/highlight/detail?id=2514739123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514739123?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:46","pubTimestamp":1740721594,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2AE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GTG.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2514831397","title":"Small companies, big swings and four future leaders that stand out","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831397","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514831397?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:12","pubTimestamp":1740719546,"startTime":"0","endTime":"0","summary":"In our reporting season update, I talk to Jason Guthrie about another volatile reporting season in the small to mid-cap end of the ASX. As always there have been many winners and losers and I discuss the trends we are seeing, including margin pressures and a reckoning for some of the best performing companies and sectors of recent months. I also outline the performance of a some of IML’s key holdings including Mayne Pharma , oOh!Media , Integral Diagnostics  and Light & Wonder .So, it’s been very volatile, but I think if we look at the reporting season in totality, the key messages we can take away are that consumers are still fairly price-conscious and value-conscious, but it’s not diabolical in terms of how the consumer is performing. If you look at the revenue lines that many of the companies have reported this reporting season, that’s actually held up OK. Companies are growing their top line o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/small-companies-big-swings-and-four-future-leaders-that-stand-out","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/small-companies-big-swings-and-four-future-leaders-that-stand-out","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["SWM.AU","BK7124","BK7508","LNW.AU","BK7045","IDX.AU","BK7078","OML.AU","BK7052","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2514998163","title":"Cann Group Ltd - Hy Loss From Ordinary Activities After Tax a$10.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514998163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514998163?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:10","pubTimestamp":1740719433,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7502","BK7096","CAN.AU","BK7508"],"gpt_icon":0},{"id":"2514393082","title":"Proteomics Opens Certified Clinical Laboratory in California; Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514393082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514393082?lang=en_us&edition=fundamental","pubTime":"2025-02-28 12:18","pubTimestamp":1740716328,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  has opened a clinical laboratory improvement amendments  certified reference laboratory in Irvine, California, according to a Friday filing with the Australian bourse.The company has secured both a California State License and the CLIA certification, allowing it to operate as a certified clinical laboratory within the US, the filing said.The laboratory will initially offer the PromarkerD test, which predicts diabetes-related chronic kidney disease , and plans to expand with tests for esophageal cancer and endometriosis, the filing added.The launch of PromarkerD, shown to predict DKD up to four years in advance, is expected in the second quarter, the company said.The laboratory is designed for scalability, allowing Proteomics International to introduce additional diagnostic tests efficiently in the US market, the company added.Shares of the company fell 8% in recent Friday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLIA","PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2514934053","title":"Why did the ASX 200 go backwards in February?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514934053","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514934053?lang=en_us&edition=fundamental","pubTime":"2025-02-28 11:07","pubTimestamp":1740712025,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index(ASX: XJO) is down 0.7% in afternoon trade on Friday. Barring a last minute miracle, that means the benchmark Aussie index will have gone backwards over the month. The ASX 200 clo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/28/why-did-the-asx-200-go-backwards-in-february/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7135","BHP.AU","XJO.AU","BK7141","BK7067","XAO.AU","BK7507","BK7505","XKO.AU","BK7095","CBA.AU","BK7501","BK7508","A2M.AU","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2514024361","title":"Neuren Pharmaceuticals Receives First Milestone Payment for Rett Syndrome Drug; Shares Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514024361","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514024361?lang=en_us&edition=fundamental","pubTime":"2025-02-28 10:17","pubTimestamp":1740709061,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  received its first sales milestone payment of $50 million for the first year that the net sales of Rett syndrome drug Daybue exceeded $250 million in North America, according to a Friday filing with the Australian bourse.The company's Nasdaq-listed partner Acadia Pharmaceuticals reported $348.4 million net sales of the drug in the US in 2024, the filing said.The company will receive the second milestone payment from commercialization of the drug when net sales exceed $500 million, according to the filing.Neuren Pharmaceuticals shares fell 6% in afternoon trade Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NEU.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2514366827","title":"BRIEF-Biotron Says Renounceable Rights Issue To Raise Up To A$2.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514366827","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514366827?lang=en_us&edition=fundamental","pubTime":"2025-02-28 09:35","pubTimestamp":1740706505,"startTime":"0","endTime":"0","summary":"BRIEF-Biotron Says Renounceable Rights Issue To Raise Up To A$2.7 MillionFeb 28 (Reuters) - Biotron Ltd BIT.AX:RENOUNCEABLE RIGHTS ISSUE TO RAISE UP TO A$2.7 MILLIONISSUE PRICE OF 0.3 AU CENTS PER SHAREFurther company coverage: BIT.AX ((Reuters.Briefs@thomsonreuters.com))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIT.AU","BK7501","BK7508","BK7067"],"gpt_icon":0}],"pageSize":16,"totalPage":10,"pageCount":4,"totalSize":147}]}}